Audentes Therapeutics, Inc. Stock-Based Compensation
Audentes Therapeutics, Inc. reported Stock-Based Compensation of $17.34 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2019-11-07
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $5.71M, a 23.29% increase year-over-year.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $6.13M, a 49.65% increase year-over-year.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $5.50M, a 62.48% increase year-over-year.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $4.38M, a 54.93% increase year-over-year.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $16.50M, a 139.75% increase from fiscal 2017.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $6.88M, a 243.31% increase from fiscal 2016.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $2.00M, a 55.23% increase from fiscal 2015.
- Audentes Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $1.29M, a 150.68% increase from fiscal 2014.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $5.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.84M derived: sum of 2 quarters · filed 2019-11-07 | $17.34M 10-Q · filed 2019-11-07 | $21.72M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $11.63M 10-Q · filed 2019-08-07 | $16.01M derived: sum of 3 quarters · filed 2019-08-07 | $20.64M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | $5.50M 10-Q · filed 2019-05-08 | $9.88M derived: sum of 2 quarters · filed 2019-05-08 | $14.51M derived: sum of 3 quarters · filed 2019-11-07 | $18.61M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $9.01M derived: sum of 2 quarters · filed 2019-11-07 | $13.11M derived: sum of 3 quarters · filed 2019-11-07 | $16.50M 10-K · filed 2019-03-01 |
| 2018-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $8.73M derived: sum of 2 quarters · filed 2019-11-07 | $12.12M 10-Q · filed 2019-11-07 | $14.94M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $7.48M 10-Q · filed 2019-08-07 | $10.31M derived: sum of 3 quarters · filed 2019-08-07 | $11.84M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $3.38M 10-Q · filed 2019-05-08 | $6.21M derived: sum of 2 quarters · filed 2019-05-08 | $7.74M derived: sum of 3 quarters · filed 2019-05-08 | $9.21M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.36M derived: sum of 2 quarters · filed 2019-03-01 | $5.83M derived: sum of 3 quarters · filed 2019-03-01 | $6.88M 10-K · filed 2019-03-01 |
| 2017-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $3.00M derived: sum of 2 quarters · filed 2018-11-07 | $4.05M 10-Q · filed 2018-11-07 | $4.75M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.52M 10-Q · filed 2018-08-07 | $3.22M derived: sum of 3 quarters · filed 2019-03-01 | $3.82M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $1.05M 10-Q · filed 2018-05-10 | $1.75M derived: sum of 2 quarters · filed 2019-03-01 | $2.35M derived: sum of 3 quarters · filed 2019-03-01 | $2.73M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.30M derived: sum of 2 quarters · filed 2019-03-01 | $1.68M derived: sum of 3 quarters · filed 2019-03-01 | $2.00M 10-K · filed 2019-03-01 |
| 2016-09-30 | $599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $979.00K derived: sum of 2 quarters · filed 2017-11-14 | $1.31M 10-Q · filed 2017-11-14 | $2.12M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $380.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $707.00K 10-Q · filed 2017-08-10 | $1.52M derived: sum of 3 quarters · filed 2018-03-09 | $1.68M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $327.00K 10-Q · filed 2017-05-11 | $1.14M derived: sum of 2 quarters · filed 2018-03-09 | $1.30M derived: sum of 3 quarters · filed 2018-03-09 | |
| 2015-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $971.00K derived: sum of 2 quarters · filed 2018-03-09 | $1.29M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $478.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $320.00K 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | $515.00K 10-K · filed 2017-03-13 |